MSLN and colorectal carcinoma: We have shown that increased MSLN expression is positively correlated with right-sided CRC, CMS1, and CMS4 molecular subtypes, possibly playing a role in the poor prognosis associated with right-sided CRC and CMS1/4 molecular subtypes [34, 35].